welcomes you to the new, improved website!
Jin Wu
BACKGROUND
Northwestern Memorial Hospital 07/2025-06/2026 Chicago, IL Department of Cardiothoracic Surgery, Aortic FellowshipAlbert Einstein Montefiore 07/2023 – 06/2025 Bronx, NY Department of Cardiothoracic Surgery, FellowshipOhioHealth Riverside Methodist Hospital 06/2018 – 06/2023 Columbus, OH Department of General Surgery, ResidencyThe University of Toledo College of Medicine and Life Sciences 08/2014 – 05/2018 Toledo, OHThe Ohio State University 09/2010 – 05/2014 Columbus, OH
OTHER INTERESTS
RESEARCH
Hershenhouse, K., Ferrell, B., Glezer, E., Wu, J., & Goldstein, D. Expert Review: A Profile of the Impella 5.5 for the Clinical Management of Cardiogenic Shock and a Review of the Current Indications for Use and Future Directions. Expert Review of Medical Devices, December 2024. PMID: 39604145.
Varre, J., Hopmann, P., Wu, J., Bach, J., Suh, K., Goslin B., & DeVoe W. In- and out-of-hospital outcomes following surgical stabilization of rib fractures in 80 years and older: a single-institution experience. Injury, June 2023. PMID: 37353448.
Saraswat, N., Werwie, N., Wu, J., Hery, D., Saunders, E., Bundy, H., Elliott, J., Goslin, B., & DeVoe, W. Postoperative Outcomes Following Surgical Stabilization of Rib Fractures Stratified by 5-Factor Modified Frailty Index. The Journal of Cardiothoracic Trauma, December 2022.
Ghazoul, G., Hery, D., Wu, J., Kim, W. Management of an intercostal-pulmonary fistula in the setting of massive hemoptysis. Case Reports International, October 2022.
Varre, J., Wu, J., Hopmann, P., Ruiz, O., & Reddy, R. Endoscopic and Surgical Management of Bouveret’s Syndrome Complicated By Gallstone Ileus. Journal of Surgical Case Reports, October 2021. PMID: 34729172.
Wu, J., Saraswat, N., Harris, K., Goslin, B., & DeVoe, W. Surgical Stabilization of Rib Fractures in Symptomatic COVID-19: A Case Report. Trauma Case Report, August 2021. PMID: 34458543.
Oliver, M., Mitro, G., Tenbrink, P., Alharthi, S., Bedford, N., Wu, J., Gohara, A., Jordan, M., Zaremba, C., Rees, M., & Ortiz, J. No Increased Risk of Posttransplant Lymphoproliferative Disorder Following Alemtuzumab Induction in Kidney Transplantation. Experimental and Clinical Transplantation, June 2019. PMID: 29363415.